4.7 Review

Adrenomedullin in lymphangiogenesis: from development to disease

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 72, Issue 16, Pages 3115-3126

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-015-1921-3

Keywords

Lymphedema; Calcitonin receptor-like receptor (CLR = protein; Calcrl = gene); Receptor activity modifying protein (RAMP); CXCR7

Funding

  1. UNC-CH University Cancer Research Innovation Award and U.S. National Institutes of Health [HD060860, DK099156, HL118932]

Ask authors/readers for more resources

Over the past decade, we have begun to appreciate that the lymphatic vascular system does more than simply return plasma back into the circulatory system and, in fact, contributes to a wide variety of normal and disease states. For this reason, much research has been devoted to understanding how lymphatic vessels form and function, with a particular interest in which molecules contribute to lymphatic vessel growth and maintenance. In the following review, we focus on a potent lymphangiogenic factor, adrenomedullin, and its known roles in lymphangiogenesis, lymphatic function, and human lymphatic disease. As one of the first, pharmacologically tractable G protein-coupled receptor pathways characterized in lymphatic endothelial cells, the continued study of adrenomedullin effects on the lymphatic system may open new avenues for the modulation of lymphatic growth and function in a variety of lymphatic-related diseases that currently have few treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available